Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.47 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CFD | P00746 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31006941 | 1.00 | CYP4F2 (0.47) | CYP4F2CYP4A11TNFSF11KDM4EALDH1A1 | |
| SCHEMBL12474133 | 0.84 | CYP4F2 (0.45) | CYP4F2CYP4A11TNFSF11KDM4EALDH1A1 | |
| SCHEMBL24436820 | 0.84 | CYP4F2 (0.45) | CYP4F2CYP4A11TNFSF11KDM4EALDH1A1 | |
| SCHEMBL474387 | 0.83 | CES2 (0.39) | CYP4F2CYP4A11MAPTCES2CES1 | |
| SCHEMBL7646091 | 0.82 | ELANE (0.37) | CYP4F2CYP4A11ALDH1A1GAARAB9A | |
| SCHEMBL7711877 | 0.82 | CYP4F2 (0.44) | CYP4F2CYP4A11TNFSF11KDM4EALDH1A1 | |
| SCHEMBL1998350 | 0.82 | CYP4F2 (0.46) | CYP4F2CYP4A11TNFSF11KDM4EALDH1A1 | |
| SCHEMBL24445897 | 0.82 | CYP4F2 (0.42) | CYP4F2CYP4A11TNFSF11KDM4EALDH1A1 | |
| SCHEMBL20156673 | 0.81 | CES2 (0.38) | CYP4F2CYP4A11RAB9APOLBLMNA | |
| SCHEMBL24436812 | 0.80 | CYP4F2 (0.45) | CYP4F2CYP4A11TNFSF11KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118973617-A | Conjugates, compositions, and methods of use | 维尔托索宾科公司 | 2024-11-15 | — | — | CN | disclosed |
| EP-4460330-A1 | CONJUGATES, COMPOSITIONS AND METHODS OF USE | Virtuoso Binco, Inc. (US) | 2024-11-13 | — | — | EP | disclosed |
| EP-4293112-A2 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | Genzyme Corporation (US) | 2023-12-20 | — | — | EP | disclosed |
| EP-3597655-B1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORP (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023131219-A1 | CONJUGATES, COMPOSITIONS AND METHODS OF USE | VIRTUOSO BINCO, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20220204963-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORPORATION | 2022-06-30 | — | — | US | disclosed |
| US-10907142-B2 | Oligosaccharides comprising an aminooxy group and conjugates thereof | GENZYME CORPORATION (US) | 2021-02-02 | — | — | US | disclosed |
| EP-2457919-B1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORP (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-2457920-B1 | Oligosaccharides comprising an aminooxy group and conjugates thereof | GENZYME CORP (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2017072662-A1 | ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST | NOVARTIS AG (CH) | 2017-05-04 | — | — | WO | disclosed |
| US-20100284860-A1 | MOLECULES SUITABLE FOR BINDING TO A METAL LAYER FOR COVALENTLY IMMOBILIZING BIOMOLECULES | IMEC (BE) | 2010-11-11 | — | — | US | disclosed |
| US-7770437-B2 | Thiol or disulfide molecules having poly(ethylene oxide) groups for use in a self assembled monolayer bound to a metal layer for covalently immobilizing biomolecules in a biosensor | IMEC (BE) | 2010-08-10 | — | — | US | disclosed |
| US-7770437-B2 | Thiol or disulfide molecules having poly(ethylene oxide) groups for use in a self assembled monolayer bound to a metal layer for covalently immobilizing biomolecules in a biosensor | IMEC (BE) | 2010-08-10 | — | — | US | disclosed |
| US-20100047225-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
| EP-2121713-A2 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | Genzyme Corporation (US) | 2009-11-25 | — | — | EP | disclosed |
| EP-1798250-B1 | Molecules suitable for binding to a metal layer for covalently immobilizing biomolecules | IMEC INTER UNI MICRO ELECTR (BE) | 2008-09-03 | — | — | EP | disclosed |
| WO-2008089403-A2 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | GENZYME CORPORATION (US) | 2008-07-24 | — | — | WO | disclosed |
| US-20070272003-A1 | 2-(2-{2-[2-(2-{2-[2-(11-mercaptoyldisulfanyl-undecyloxy)ethoxy]ethoxy}ethoxy)ethoxy]ethoxy} acetic acid pentafluorophenyl ester; poly(ethylene oxide) groups resist nonspecific adsorption and enhance the specific affinity interactions | IMEC (BE) | 2007-11-29 | — | — | US | disclosed |
| US-20070272003-A1 | 2-(2-{2-[2-(2-{2-[2-(11-mercaptoyldisulfanyl-undecyloxy)ethoxy]ethoxy}ethoxy)ethoxy]ethoxy} acetic acid pentafluorophenyl ester; poly(ethylene oxide) groups resist nonspecific adsorption and enhance the specific affinity interactions | IMEC (BE) | 2007-11-29 | — | — | US | disclosed |
| EP-1798250-A2 | Molecules suitable for binding to a metal layer for covalently immobilizing biomolecules | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM vzw (IMEC) (BE) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10907142-B2 | Oligosaccharides comprising an aminooxy group and conjugates thereof | MAN2B1, MAN1B1, GAA | CYP4F2 3324/4885CYP4A11 3392/4885TNFSF11 1147/4885 |
| US-20220204963-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | MAN2B1, MAN1B1, GAA | CYP4F2 3324/4885CYP4A11 3392/4885TNFSF11 1147/4885 |
| US-20100047225-A1 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | MAN2B1, MAN1B1, GAA | CYP4F2 3324/4885CYP4A11 3392/4885TNFSF11 1147/4885 |
| US-20100284860-A1 | MOLECULES SUITABLE FOR BINDING TO A METAL LAYER FOR COVALENTLY IMMOBILIZING BIOMOLECULES | EBPL, SPR, MB | CYP4F2 2365/4885CYP4A11 4804/4885TNFSF11 476/4885 |
| US-20070272003-A1 | 2-(2-{2-[2-(2-{2-[2-(11-mercaptoyldisulfanyl-undecyloxy)ethoxy]ethoxy}ethoxy)ethoxy]ethoxy} acetic acid pentafluorophenyl ester; poly(ethylene oxide) groups resist nonspecific adsorption and enhance the specific affinity interactions | EBPL, AEBP2, NAPA | CYP4F2 1008/4885CYP4A11 4322/4885TNFSF11 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.